Concerns over exaggerated health claims prompts FDA hearing on effects of CBD products

Cannabis-related products have flooded the market, making health claims about pain relief, immune function and anxiety and depression. On Friday, the US Food and Drug Administration is holding its first hearing to assess the safety and efficacy of these CBD products.

Source:: CNN Politics